[Translation] A single-center, single-dose, two-preparation, two-cycle, two-sequence, open-label, randomized, crossover bioequivalence study of metformin hydrochloride extended-release tablets
主要试验目的:在健康受试者体内,分别在空腹和餐后条件下,以Merck Serono Limited持有的盐酸二甲双胍缓释片(商品名:Glucophage XR;规格:0.5 g)为参比制剂,研究山东博山制药有限公司的盐酸二甲双胍缓释片(规格:0.5 g;受试制剂)的吸收速度与吸收程度,评价受试制剂与参比制剂是否具有生物等效性。
次要试验目的:观察受试制剂和参比制剂在健康受试者中的安全性。
[Translation] The main purpose of the study is to study the absorption rate and extent of metformin hydrochloride sustained-release tablets (specification: 0.5 g; test preparation) of Shandong Boshan Pharmaceutical Co., Ltd. under fasting and postprandial conditions in healthy subjects, using metformin hydrochloride sustained-release tablets (trade name: Glucophage XR; specification: 0.5 g) held by Merck Serono Limited as the reference preparation, and to evaluate whether the test preparation and the reference preparation are bioequivalent.
Secondary purpose of the study: to observe the safety of the test preparation and the reference preparation in healthy subjects.